Who invested in Synosia Therapeutics?
Synosia Therapeutics's investors include Versant Ventures, 5AM Ventures, Novo Holdings A/S, Investor AB and Abingworth, and 4 more on record.
Switzerland · Series C startup
Funding summaryUpdated 26 Oct 2026
$92Mraised across 3 rounds since 2007, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by synosia.com
Reported by fiercebiotech.com
Reported by deals.venturebeat.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Synosia Therapeutics's investors include Versant Ventures, 5AM Ventures, Novo Holdings A/S, Investor AB and Abingworth, and 4 more on record.
Synosia Therapeutics has raised $92M across 3 rounds since 2007.
Synosia Therapeutics's most recent round was a Series C of $30M in Oct 2010.
Synosia Therapeutics's largest round on record is $33M (Venture), in Jan 2007.
Synosia Therapeutics's first round on record, in Jan 2007, was backed by Versant Ventures, 5AM Ventures and Novo Holdings A/S and 1 others.
Synosia Therapeutics's latest named round is a Series C, in Oct 2010.
Synosia Therapeutics is based in Switzerland.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.